Buyer · Federal
Ministry of Social Affairs and Health
Helsinki · Helsinki-Uusimaa
Track this recordFree account — get alerted when a contract here runs out.
Awards
3
Total awarded
€18.7m
3 / 3 with a value
Suppliers
3
Last updated
25 Sept 2026
Current incumbents
| Sector | Supplier | Contract value | Contract end |
|---|---|---|---|
| Medical equipment and pharmaceuticals | GlaxoSmithKline Oy | €2,556,000 | 23 Sept 2027estimated |
Awards
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| Hepatitis B (HBV) vaccine for children and adults 2027-2029 (2029-2030,2030-2031) | Ministry of Social Affairs and Health | GlaxoSmithKline Oy | €2,556,000 | 25 Sept 2026 |
| Measles, mumps and rubella (MMR) vaccine 2027-2028 (2029, 2030) | Ministry of Social Affairs and Health | MSD Finland Oy | €5,097,600 | 7 Sept 2026 |
| Pentavalent (DTaP-IPV+Hib) vaccine 2027-2028 (2029, 2030, 2031) | Ministry of Social Affairs and Health | Sanofi Oy | €11,088,000 | 7 Sept 2026 |